Patents by Inventor Santos Susin

Santos Susin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and pharmaceutical composition for use in the treatment of cancer
    Patent number: 10759843
    Abstract: The present invention relates to a soluble peptide comprising the amino acids sequence: KRFYVVMWKK (SEQ ID NO:1) or a function-conservative variant thereof for use in the treatment of cancer. The invention also relates to a pharmaceutical composition for use in the treatment of cancer comprising at least one soluble peptide according to the invention or at least one acid nucleic according to the invention or at least one expression vector according to the invention, or at least one host cell according to the invention and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: September 1, 2020
    Inventors: Santos Susin, Pierre Launay, Philippe Karoyan, Helene Merle-Beral
  • NEW COMPOUNDS AND PHARMACEUTICAL USE THEREOF IN THE TREATMENT OF CANCER
    Publication number: 20190144501
    Abstract: The present invention relates to a compound or a pharmaceutical salt thereof comprising a hexapeptide sequence of formula (I), its method of synthesis and its use in anticancer therapy. The invention also relates to a pharmaceutical composition for use in the treatment of cancer comprising at least one soluble peptide according to the invention or at least one acid nucleic according to the invention or at least one expression vector according to the invention, or at least one host cell according to the invention and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: May 10, 2017
    Publication date: May 16, 2019
    Inventors: Santos A. Susin, Philippe Karoyan, Hélène Merle-Beral
  • METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20190135898
    Abstract: The present invention relates to a soluble peptide comprising the amino acids sequence: KRFYVVMWKK (SEQ ID NO:1) or a function-conservative variant thereof for use in the treatment of cancer. The invention also relates to a pharmaceutical composition for use in the treatment of cancer comprising at least one soluble peptide according to the invention or at least one acid nucleic according to the invention or at least one expression vector according to the invention, or at least one host cell according to the invention and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: October 16, 2018
    Publication date: May 9, 2019
    Inventors: Santos Susin, Pierre Launay, Philippe Karoyan, Helene Merle-Beral
  • Method and Pharmaceutical Composition for Use in the Treatment of Cancer
    Publication number: 20170362302
    Abstract: The present invention relates to a soluble peptide comprising the amino acids sequence: KRFYVVMWKK (SEQ ID NO: 1) or a function-conservative variant thereof for use in the treatment of cancer. The invention also relates to a pharmaceutical composition for use in the treatment of cancer comprising at least one soluble peptide according to the invention or at least one acid nucleic according to the invention or at least one expression vector according to the invention, or at least one host cell according to the invention and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: August 28, 2017
    Publication date: December 21, 2017
    Inventors: Santos Susin, Pierre Launay, Philippe Karoyan, Helene Merle-Beral
  • Method and Pharmaceutical Composition for use in the Treatment of Cancer
    Publication number: 20160039908
    Abstract: The present invention relates to a soluble peptide comprising the amino acids sequence: KRFYVVMWKK (SEQ ID NO: 1) or a function-conservative variant thereof for use in the treatment of cancer. The invention also relates to a pharmaceutical composition for use in the treatment of cancer comprising at least one soluble peptide according to the invention or at least one acid nucleic according to the invention or at least one expression vector according to the invention, or at least one host cell according to the invention and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: October 5, 2015
    Publication date: February 11, 2016
    Inventors: Santos Susin, Pierre Launay, Philippe Karoyan, Helene Merle-Beral
  • Method and pharmaceutical composition for use in the treatment of cancer
    Patent number: 9198949
    Abstract: The present invention relates to a soluble peptide comprising the amino acids sequence: KRFYVVMWKK (SEQ ID NO: 1) or a function-conservative variant thereof for use in the treatment of cancer. The invention also relates to a pharmaceutical composition for use in the treatment of cancer comprising at least one soluble peptide according to the invention or at least one acid nucleic according to the invention or at least one expression vector according to the invention, or at least one host cell according to the invention and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: June 6, 2013
    Date of Patent: December 1, 2015
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PIERRE ET MARIE CURIE UPMC, UNIVERSITE PARIS DIDEROT-PARIS 7, UNIVERSITE PARIS DESCARTES, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
    Inventors: Santos Susin, Pierre Launay, Philippe Karoyan, Helene Merle-Beral
  • Method and Pharmaceutical Composition for use in the Treatment of Cancer
    Publication number: 20150126456
    Abstract: The present invention relates to a soluble peptide comprising the amino acids sequence: KRFYVVMWKK (SEQ ID NO: 1) or a function-conservative variant thereof for use in the treatment of cancer. The invention also relates to a pharmaceutical composition for use in the treatment of cancer comprising at least one soluble peptide according to the invention or at least one acid nucleic according to the invention or at least one expression vector according to the invention, or at least one host cell according to the invention and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: June 6, 2013
    Publication date: May 7, 2015
    Inventors: Santos Susin, Pierre Launay, Philippe Karoyan, Helene Merle-Beral
  • Apoptosis-inducing factor
    Patent number: 7371834
    Abstract: The present invention related generally novel mammalian apoptosis-inducing factors, polynucleotides encoding such factors and methods related thereto.
    Type: Grant
    Filed: December 2, 2002
    Date of Patent: May 13, 2008
    Assignees: Amgen Inc., Centre National de la Recherche Scientifique
    Inventors: Josef M. Penninger, Guido P. Kroemer, David Peter Siderovski, Naoufal Zamzami, Santos A. Susin, Bryan E. L. Snow
  • Apoptosis-inducing factor
    Patent number: 6773911
    Abstract: The present invention related generally novel mammalian apoptosis-inducing factors, polynucleotides encoding such factors and methods related thereto.
    Type: Grant
    Filed: November 23, 1999
    Date of Patent: August 10, 2004
    Assignees: Amgen Canada Inc., Centre National de la Recherche Scientifique
    Inventors: Josef M. Penninger, Guido P. Kroemer, David Peter Siderovski, Naoufal Zamzami, Santos A. Susin, Bryan E. L. Snow
  • Apoptosis-inducing factor
    Publication number: 20030211514
    Abstract: The present invention related generally novel mammalian apoptosis-inducing factors, polynucleotides encoding such factors and methods related thereto.
    Type: Application
    Filed: December 2, 2002
    Publication date: November 13, 2003
    Inventors: Josef M. Penninger, Guido P. Kroemer, David Peter Siderovski, Naoufal Zamzami, Santos A. Susin, Bryan E.L. Snow